Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Second solid tumors in childhood. Review based on three cases].

I Astigarraga Aguirre1, A Navajas Gutiérrez, A Rivera Aranda

  • 1Unidad de Oncología Infantil, Departamento de Pediatría, Hospital de Cruces de Baracaldo, Vizaya.

Anales Espanoles De Pediatria
|July 1, 1991
PubMed
Summary

Longer survival for childhood cancer survivors increases second cancer risks. This study details three cases and reviews factors contributing to secondary solid tumors in pediatric cancer patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Paracentesis as abdominal decompression therapy in neuroblastoma MS with massive hepatomegaly].

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica·2018
Same author

[Multiple cavernomatosis: a review and presentation of a familial case].

Anales de pediatria (Barcelona, Spain : 2003)·2014
Same author

[Update on L-asparaginase treatment in paediatrics].

Anales de pediatria (Barcelona, Spain : 2003)·2013
Same author

[Familial splenomegaly as a first clinical sign of autoimmune lymphoproliferative syndrome].

Anales de pediatria (Barcelona, Spain : 2003)·2010
Same author

[Paediatric one-stop surgery: a series of 75 cases].

Revista de calidad asistencial : organo de la Sociedad Espanola de Calidad Asistencial·2009
Same author

[Subcutaneous nodules as a sign of malignant lymphoproliferative syndrome].

Anales de pediatria (Barcelona, Spain : 2003)·2009

Area of Science:

  • Pediatric Oncology
  • Cancer Genetics
  • Tumorigenesis

Background:

  • Childhood cancer survival rates have improved significantly.
  • This has led to an increased incidence of second malignant neoplasms (SMNs).
  • Understanding SMN development is crucial for long-term pediatric cancer care.

Observation:

  • Three pediatric cases of SMNs are presented.
  • Cases include osteosarcoma after retinoblastoma, astrocytoma with acute lymphoblastic leukemia, and glioblastoma with neurofibromatosis and Non-Hodgkin lymphoma.
  • The time intervals between initial diagnosis and SMN ranged from 2 to 12 years.

Findings:

  • Genetic predisposition, immunologic factors, and therapeutic interventions are implicated in SMN development.
  • Specific genetic syndromes (e.g., neurofibromatosis) and prior cancer treatments can increase risk.

Related Experiment Videos

  • The interplay of these factors requires further investigation.

    • Implications:

    • Improved surveillance strategies for pediatric cancer survivors are needed.
    • Personalized risk assessment for SMNs should be considered.
    • Further research into the mechanisms of secondary tumorigenesis can inform prevention and treatment.